Article
Optimizing Primary Analyses in Randomized Controlled Trials with Multiple Endpoints: A Simulation Study with Application to Kidney Transplantation
2025-10-07
Abstract excerpt
<title>Abstract</title> <p>Relying on a single primary endpoint in randomized controlled trials (RCTs) is often not feasible, e.g. due to low event rates. We explored three approaches to consider multiple endpoints in the primary analysis of RCTs, as stated in the FDA and EMA guidelines on multiplicity issues: (i) a composite endpoint (CE), (ii) multiple testing and multiplicity correction (MTMC), and (iii) a hie...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0f5f8f6e-649e-5b64-b8dc-377749be4aa1
- DOI
- 10.21203/rs.3.rs-7591828/v1
